REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $164,972 | +12.1% | 1,618 | 0.0% | 0.03% | +16.0% |
| Q1 2023 | $147,109 | +139.3% | 1,618 | 0.0% | 0.02% | +150.0% |
| Q4 2022 | $61,468 | +49.9% | 1,618 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $41,000 | -35.9% | 1,618 | -23.6% | 0.01% | -33.3% |
| Q2 2022 | $64,000 | -7.2% | 2,118 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $69,000 | +23.2% | 2,118 | 0.0% | 0.01% | +9.1% |
| Q4 2021 | $56,000 | -79.3% | 2,118 | -21.1% | 0.01% | -80.4% |
| Q3 2021 | $270,000 | -28.9% | 2,683 | 0.0% | 0.06% | -30.9% |
| Q2 2021 | $380,000 | +42.3% | 2,683 | 0.0% | 0.08% | +28.6% |
| Q1 2021 | $267,000 | -25.4% | 2,683 | -7.4% | 0.06% | -32.3% |
| Q4 2020 | $358,000 | +27.0% | 2,897 | 0.0% | 0.09% | +17.7% |
| Q3 2020 | $282,000 | -23.0% | 2,897 | +23.4% | 0.08% | -22.5% |
| Q2 2020 | $366,000 | +8.0% | 2,347 | 0.0% | 0.10% | -8.9% |
| Q1 2020 | $339,000 | -22.2% | 2,347 | +10.0% | 0.11% | +19.1% |
| Q4 2019 | $436,000 | +155.0% | 2,133 | 0.0% | 0.09% | +147.4% |
| Q3 2019 | $171,000 | -14.9% | 2,133 | 0.0% | 0.04% | -15.6% |
| Q2 2019 | $201,000 | +50.0% | 2,133 | +36.0% | 0.04% | +45.2% |
| Q1 2019 | $134,000 | +52.3% | 1,568 | 0.0% | 0.03% | +29.2% |
| Q4 2018 | $88,000 | -31.2% | 1,568 | 0.0% | 0.02% | -22.6% |
| Q3 2018 | $128,000 | – | 1,568 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |